Skip to main content
. 2013 Feb 13;8(2):e54841. doi: 10.1371/journal.pone.0054841

Table 1. The clinical evaluation of EAE mice.

Group n Incidence ( % ) Mean onset date Mean score of maximal symptom
EAE control 13 100 12.38±1.45 2.62±1.08
Fasudil late 13 76.9 13.50±2.17 1.41±1.08*
Fasudil early 13 23.1* 18.00±3.61* 0.30±0.72**

Fasudil was injected (i.p.) at 40 mg/kg/d every other day on day 3 p.i. (Fasudil early treatment) and on day 11 p.i. (Fasudil late treatment). The injection of normal saline was set up as control (EAE control) in a similar manner. Data are presented as mean ± S.E.M.

*

p<0.05,

**

p<0.01.

HHS Vulnerability Disclosure